Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The objectives of this study were to examine the cardiovascular sensitivity to oral tyramine
after establishment of steady state with CX157 Modified Release (MR) Tablets, 125 mg
administered twice per day (BID) in healthy volunteers compared to placebo; and to
investigate the general safety, tolerability and pharmacokinetic profile of CX157 tablets at
steady state compared to placebo.